We are live on ! Find out more
KBG

Kahn Brothers Group Portfolio holdings

AUM $564M
1-Year Est. Return 25.3%
This Fund
S&P 500
This Quarter Est. Return
+17.16%
1 Year Est. Return
+25.3%
3 Year Est. Return
+38.07%
5 Year Est. Return
+72.96%
10 Year Est. Return
+308.37%
AUM
$640M
AUM Growth
+$85.4M
Cap. Flow
-$15.5M
Cap. Flow %
-2.43%
Top 10 Hldgs %
76.22%
Holding
32
New
1
Increased
3
Reduced
24
Closed

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$24.1M
2
PTEN icon
Patterson-UTI
PTEN
+$1.33M
3
GSK icon
GSK
GSK
+$624K

Top Sells

Rank Stock Value
1
NYT icon
New York Times
NYT
+$16.5M
2
HOLX
Hologic
HOLX
+$9.46M
3
MRK icon
Merck
MRK
+$3.71M
4
STL
Sterling Bancorp
STL
+$2.8M
5
BP icon
BP
BP
+$2.03M

Sector Composition

Rank Sector Weight
1 Financials 33.44%
2 Healthcare 29.35%
3 Energy 13.44%
4 Technology 9.78%
5 Consumer Staples 4.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
1
Merck
MRK
$315B
$69.1M 10.8%
871,291
-49,652
-5% -$3.71M
BP icon
2
BP
BP
$108B
$59.9M 9.37%
1,394,116
-49,629
-3% -$2.03M
C icon
3
Citigroup
C
$217B
$57.3M 8.95%
920,627
-26,466
-3% -$1.64M
AGO icon
4
Assured Guaranty
AGO
$3.76B
$55.1M 8.6%
1,239,520
-22,065
-2% -$919K
GSK icon
5
GSK
GSK
$104B
$53.3M 8.34%
1,021,240
+12,488
+1% +$624K
FLG
6
Flagstar Bank National Association
FLG
$6.21B
$49.6M 7.75%
1,428,977
-13,483
-0.9% -$464K
BB icon
7
BlackBerry
BB
$5.27B
$46M 7.19%
4,561,825
-24,400
-0.5% -$205K
MBI icon
8
MBIA
MBI
$333M
$42M 6.56%
4,412,482
-119,428
-3% -$1.17M
SEB icon
9
Seaboard Corp
SEB
$4.34B
$31.4M 4.9%
7,325
-364
-5% -$1.4M
BMY icon
10
Bristol-Myers Squibb
BMY
$124B
$24.1M 3.76%
504,350
+484,400
+2,428% +$24.1M
PTEN icon
11
Patterson-UTI
PTEN
$3.8B
$24M 3.74%
1,709,129
+101,332
+6% +$1.33M
PFE icon
12
Pfizer
PFE
$143B
$22.7M 3.54%
562,403
-864
-0.2% -$34.6K
NYT icon
13
New York Times
NYT
$12.3B
$22.1M 3.45%
672,512
-557,610
-45% -$16.5M
NTP
14
DELISTED
Nam Tai Property Inc.
NTP
$18.5M 2.89%
1,876,529
-22,621
-1% -$207K
HOLX
15
DELISTED
Hologic
HOLX
$16.5M 2.57%
340,444
-209,704
-38% -$9.46M
VOXX
16
DELISTED
VOXX International Corporation Class A
VOXX
$16.3M 2.55%
3,537,757
-80,905
-2% -$396K
STL
17
DELISTED
Sterling Bancorp
STL
$8.43M 1.32%
452,549
-146,742
-24% -$2.8M
RFL icon
18
Rafael Holdings
RFL
$112M
$3.95M 0.62%
316,403
-5,627
-2% -$80.9K
TPHS
19
DELISTED
Trinity Place Holdings Inc.com
TPHS
$3.81M 0.59%
951,732
NVS icon
20
Novartis
NVS
$293B
$2.19M 0.34%
25,382
XOM icon
21
ExxonMobil
XOM
$611B
$1.58M 0.25%
19,574
-248
-1% -$18.9K
ORI icon
22
Old Republic International
ORI
$10.3B
$1.02M 0.16%
48,900
CVX icon
23
Chevron
CVX
$373B
$511K 0.08%
4,148
BAC icon
24
Bank of America
BAC
$430B
$334K 0.05%
12,098
-11,287
-48% -$319K
NAVI icon
25
Navient
NAVI
$813M
$295K 0.05%
25,456
-12,750
-33% -$146K

Similar funds

Kahn Brothers Group's Q1 2019 Portfolio in Review

As of Q1 2019, Kahn Brothers Group held 32 positions worth $640M, up 15% from $555M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 3.1%. Kahn Brothers Group opened 1 new position and made no exits, leaving the 32-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Energy.

  • Kahn Brothers Group added most to Bristol-Myers Squibb in Q1 2019, an estimated $24.1M increase.
  • Kahn Brothers Group's biggest Q1 2019 reduction was New York Times, cutting an estimated $16.5M.
  • Kahn Brothers Group's ten largest holdings make up 76% of its $640M portfolio in Q1 2019.
  • Kahn Brothers Group opened 1 new position and closed 0 in Q1 2019.
  • Kahn Brothers Group's portfolio value rose 15% quarter-over-quarter to $640M.

Based on Kahn Brothers Group's 13F filing for Q1 2019, filed 6 May 2019.